Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $74,412,006    

Indirect Value

   $16,676,232,797      
Total Shares   244,803,038      
Total Value   $16,750,644,803      


Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967 Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 10 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACGN Aceragen, Inc Director   –       •      –    2017-10-02 4 A $2.28 $61,868 I/I 27,135 154,498 0 -
ACGN Aceragen, Inc Director   –       •      –    2018-01-02 4 A $2.21 $61,878 I/I 27,999 163,831 0 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-29 4 B $14.12 $62,133 I/I 4,383 168,106 1.5 -
GHDX Genomic Health Inc Director   –       •      –    2007-02-13 4 B $18.26 $62,897 I/I 3,445 187,529 2.1 -
ACGN Aceragen, Inc Director   –       •      –    2018-04-02 4 A $1.62 $64,876 I/I 40,047 616,216 0 -
ACGN Aceragen, Inc Director   –       •       •   2018-07-02 4 A $1.32 $64,877 I/I 49,149 632,599 0 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-20 4 OE $15.00 $66,000 I/I 4,400 293,009 0 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-23 4 B $16.84 $72,097 I/I 4,273 182,913 1.5 -
INCY Incyte Corp Director   –       •      –    2007-11-21 4 B $8.12 $80,883 I/I 9,961 2,217,184 2.1 -
INCY Incyte Corp Director   –       •      –    2007-11-30 4 B $8.59 $83,882 I/I 9,764 2,303,333 2.1 -
INCY Incyte Corp Director   –       •      –    2007-08-02 4 B $4.99 $87,106 I/I 17,446 1,682,158 2.1 -
INCY Incyte Corp Director   –       •      –    2007-11-12 4 B $8.00 $90,132 I/I 10,943 31,708 2.1 -
GHDX Genomic Health Inc Director   –       •      –    2007-02-13 4 B $18.26 $97,185 I/I 5,323 28,332 2.1 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-19 4 B $15.81 $97,264 I/I 6,060 245,453 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-20 4 B $16.41 $107,306 I/I 6,536 177,940 1.5 -
GEVA Synageva BioPharma Corp 10% Owner   –       –       •   2003-09-26 4 B $24.76 $107,706 I/I 4,350 1,136,106 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-09-16 4 B $94.59 $109,064 I/I 1,153 13,300,993 2.25 %
INCY Incyte Corp Director   –       •      –    2007-11-20 4 B $8.10 $112,974 I/I 13,945 2,207,223 2.1 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-26 4 B $17.89 $113,049 I/I 6,304 195,858 1.5 -
GEVA Synageva BioPharma Corp 10% Owner   –       –       •   2003-09-26 4 B $24.76 $118,848 I/I 4,800 1,604,346 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2013-04-01 4 A $27.99 $119,909 I/I 4,284 277,903 0 -
INCY Incyte Corp Director   –       •      –    2007-11-26 4 B $7.94 $121,322 I/I 15,282 2,232,466 2.1 -
NGNE Neurogene 10% Owner   –       –       •   2016-01-25 4 B $10.98 $121,576 I/I 10,945 6,432,847 1.5 -
PRLD Prelude Therapeutics Inc Director   –       •       •   2021-01-27 4 OE $12.85 $133,332 I/I 10,376 9,252,951 0 -
GHDX Genomic Health Inc Director   –       •       •   2007-03-02 4 B $18.02 $137,056 I/I 7,604 1,569,539 2.25 -
  496  Records found
  1   2   3   4   5   6   7   8   9   10  11   12   13   14   15   16   17   18   19   20      
  Page 10 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us